Trials / Terminated
TerminatedNCT05840250
Continuous Glucose Monitoring and Diabetes
Improving Glucose Control and Self-Management in Adults With Type 2 Diabetes From Health Disparate Groups Using Continuous Glucose Monitoring and Education Support
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Hackensack Meridian Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is a longitudinal single-arm prospective study design. Adult patients who are African American or Hispanic with type 2 diabetes mellitus will be recruited to participate in this study. The goal of the study is to determine if the use of a continuous glucose monitoring system will improve diabetes management in persons from health disparity background. The subjects will be closely monitored for the first 3 months as they utilize the continuous glucose monitor and engage in diabetes education classes. They will then be followed for an additional 3 months to determine if they are able to maintain the same glucose control as experienced for the initial 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Continuous Glucose Monitoring and Education Support | Participants will be provided with a device to monitor their blood glucose (Abbott Free Style Libre2 Flash CGM system) along with educational materials to better understand and manage their diabetes and other supporting services. Pre and post intervention surveys will be implemented. Participants will be closely monitored for 3 months and then followed up for 3 more months for a total of 6-month participation. |
Timeline
- Start date
- 2023-05-15
- Primary completion
- 2024-09-14
- Completion
- 2024-09-14
- First posted
- 2023-05-03
- Last updated
- 2025-01-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05840250. Inclusion in this directory is not an endorsement.